Back

Should we use albumin for in shock patients?

21 March 2026 (16:40 - 16:45)
Organised by: Logo
Congress Presentation Part of: Fast-paced conundrums: things we do in the intensive care unit but we don’t know exactly why Acute Cardiac Care ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)

7 More presentations in this session

Presentation thumbnail
Why do we treat fever?
Professor A. Sionis (Barcelona, ES)
Slides Video
Presentation thumbnail
Why do we use noradrenaline in shock?
Doctor A. Sambola (Barcelona, ES)
Slides Video
Presentation thumbnail
Should we give sodium bicarb for metabolic acidosis?
Miss T. Lopez Sobrino (Barcelona, ES)
Slides Video
Presentation thumbnail
Why do we use balanced solutions instead of saline?
Doctor J. Grand (Copenhagen, DK)
Slides Video
Presentation thumbnail
Why do we use amiodarone in refractory ventricular tachycardia?
Professor B. Gorenek (Eskisehir, TR)
Slides Video

Access the full session

Session thumbnail
Fast-paced conundrums: things we do in the intensive care unit but we don’t know exactly why

The Event

Event poster

ESC Acute CardioVascular Care 2026

21 March 2026 16:40 CET
You may be interested in
thumbnail
Congress Presentation
Albumin is one of the most important prognostic predictors in heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Approach to mixed cardiogenic and septic shock
thumbnail
Congress Presentation
The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources